newsfilter
← Latest News
GlobeNewswire·

Oragenics, Inc. Announces Pricing of Public Offering

SARASOTA, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE:OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it